2018 Spring ADRC Meeting presentations
April 20 & 21, 2018 • Los Angeles, CA
Note: Following are links to available presentations from the meeting. The full agendas can be found here.
Administrators meeting
- Welcome
- Brad Glazier — Co-Chair, ADRC Administrators Steering Committee, Administrator, Indiana University
- Q&A with Nina and Cerise
- Nina Silverberg, PhD — Director, ADRC Program, NIA/NIH
- EAC meeting guidelines and panel
- Krista Moulder, PhD — Administrator, Washington University in St. Louis
- Research Education Component panel
- Anne Barz, MS (panel leader) — Administrator, Rush University
- Henry Paulson, MD, PhD — Director, University of Michigan
Biomarkers meeting
- Introduction to inter-ADRC biomarker efforts, and progress towards an inter-ADRC project to standardize A-beta42/tau/P-tau
- Douglas Galasko, MD; Co-Chair, Biomarkers Work Group, Clinical Core Leader, University of California, San Diego
- Roche Elecsys data from ADNI
- Leslie Shaw, PhD; University of Pennsylvania
- Standardization of CSF biomarkers; Neurofilament light chain protein (NFL) as a blood biomarker for neurodegeneration
- Kaj Blennow, MD; University of Gothenburg
- MarkVCID: Developing best practices and biomarker harmonization
- Donna Wilcock, PhD; Co-Chair, Biomarkers Work Group, University of Kentucky
- Opportunities for an inter-ADC biomarker initiative
- Eric Reiman, MD; Director, Arizona ADRC
- Technology enablement of digital biomarkers for the futurization of AD research
- Rhoda Au, PhD; Boston University and Framingham Study
Imaging meeting
- Overview
- Bill Jagust, MD; University of California, Berkeley
- Accomplishments to date with NACC data
- Charlie DeCarli, MD; Director, University of California, Davis
- Steering Committee responsibilities: Protocol management, data analysis, QC, etc
- Duane Beekly; Director of Computing, NACC
Directors meeting
NIA updates
- Marie Bernard, MD— Deputy Director, NIA/NIH
- Eliezer Masliah, MD — Director, Division of Neuroscience, NIA/NIH
- Nina Silverberg, PhD — Director, ADRC Program, NIA/NIH
Updates from ADRC data- and sample-sharing facilitators
- Updates from ADRC data- and sample-sharing facilitators
- Walter A. Kukull, PhD — Director, National Alzheimer's Coordinating Center
- Gerard Schellenberg, PhD — PI, Alzheimer's Disease Genetics Initiative
- Tatiana Foroud, PhD — PI, National Cell Repository for Alzheimer's Disease
- ACTC: Current status and future plans
- Imaging Workgroup: Opportunities for image acquisition and sharing across sites
- William Jagust, MD
- Paul Aisen, MD
- Fluid Biomarker Workgroup: Biospecimen standardization efforts
- Douglas Galasko, MD
- Model-AD: Model organism development and evaluation
- Bruce Lamb, PhD — Andrea Tenner, PhD
- AMP-AD: Target discovery and preclinical validation
- David Bennett, MD
- Collaboration with technology companies
- Rhoda Au, PhD
- Challenges and ethical issues of returning results of amyloid and tau status to subjects
- Jason Karlawish, MD — ORE Core Leader, University of Pennsylvania
- Carey Gleason, PhD, MS — ORE Core Co-Leader, University of Wisconsin
NIA updates
- Marie Bernard, MD— Deputy Director, NIA/NIH
- Eliezer Masliah, MD — Director, Division of Neuroscience, NIA/NIH
- Nina Silverberg, PhD — Director, ADRC Program, NIA/NIH
- Updates from ADRC data- and sample-sharing facilitators
- Walter A. Kukull, PhD — Director, National Alzheimer's Coordinating Center
- Gerard Schellenberg, PhD — PI, Alzheimer's Disease Genetics Initiative
- Tatiana Foroud, PhD — PI, National Cell Repository for Alzheimer's Disease
- ACTC: Current status and future plans
- Imaging Workgroup: Opportunities for image acquisition and sharing across sites
- William Jagust, MD
- Paul Aisen, MD
- Fluid Biomarker Workgroup: Biospecimen standardization efforts
- Douglas Galasko, MD
- Model-AD: Model organism development and evaluation
- Bruce Lamb, PhD — Andrea Tenner, PhD
- AMP-AD: Target discovery and preclinical validation
- David Bennett, MD
- Collaboration with technology companies
- Rhoda Au, PhD
- Challenges and ethical issues of returning results of amyloid and tau status to subjects
- Jason Karlawish, MD — ORE Core Leader, University of Pennsylvania
- Carey Gleason, PhD, MS — ORE Core Co-Leader, University of Wisconsin
Clinical core leaders meeting
- Welcome and overview of session
- Robert Sweet, MD; Professor of Psychiatric Neuroscience and Professor of Neurology, Chair, ADRC Clinical Core Leaders Steering Committee, Clinical Core Leader, University of Pittsburgh
- BPSD fluid biomarkers
- Elaine Peskind, MD; Co-Director, VA Northwest Network Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Friends of Alzheimer's Research, Professor of Psychiatry, University of Washington School of Medicine
- Neuropathologic correlates of BPSD
- Julia Kofler, MD; Assistant Professor of Pathology, NP Core Leader and Co-Director, University of Pittsburgh
Rising star data blitz
- Shannon Risacher, PhD — Assistant Professor of Radiology and Imaging Sciences, Co-Leader, Neuroimaging Core, Indiana University ADRC
- Hussein Yassine, MD — Assistant Professor Department of Neurology, University of Southern California, USC ADRC Co-Investigator
- David Irwin, MD — Assistant Professor of Neurology, DLB Module Leader in Clinical Core B, University of Pennsylvania
- Neelesh Nadkarni, MD, PhD — Assistant Professor of Medicine (Geriatric Medicine), Co-Investigator, Clinical Core, University of Pittsburgh
- Judy Pa, PhD — Assistant Professor of Neurology, Neuroscience, and Biomedical Engineering, Laboratory of Neuro Imaging (LONI), USC Stevens Neuroimaging and Informatics Institute, USC